TELADOC HEALTH, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
TELADOC HEALTH, INC. (TDOC) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$5.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-07-30
- TELADOC HEALTH, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$29.45M.
- TELADOC HEALTH, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was -$106.58M.
- TELADOC HEALTH, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$24.84M.
- TELADOC HEALTH, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$29.11M.
- TELADOC HEALTH, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$523.30M, a 394.09% decline from fiscal 2024.
- TELADOC HEALTH, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $177.94M, a 13.00% decline from fiscal 2023.
- TELADOC HEALTH, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $204.53M, a 629.26% increase from fiscal 2022.
- TELADOC HEALTH, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was $28.05M, a 82.68% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.51M 10-Q · filed 2026-07-30 | |||
| 2026-03-31 | -$29.45M 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | -$523.30M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$577.83M 10-Q · filed 2025-10-30 | |||
| 2025-06-30 | -$624.78M 10-Q · filed 2026-07-30 | |||
| 2025-03-31 | -$106.58M 10-Q · filed 2026-04-30 | |||
| 2024-12-31 | $177.94M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $119.62M 10-Q · filed 2025-10-30 | |||
| 2024-06-30 | $39.90M 10-Q · filed 2025-07-30 | |||
| 2024-03-31 | -$24.84M 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | $204.53M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $112.73M 10-Q · filed 2024-10-31 | |||
| 2023-06-30 | $39.70M 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | -$29.11M 10-Q · filed 2024-04-26 | |||
| 2022-12-31 | $28.05M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $12.01M 10-Q · filed 2023-10-27 | |||
| 2022-06-30 | -$10.20M 10-Q · filed 2023-07-28 | |||
| 2022-03-31 | -$56.50M 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | $161.96M 10-K · filed 2024-02-23 | |||
| 2021-09-30 | $92.20M 10-Q · filed 2022-11-02 | |||
| 2021-06-30 | $49.53M 10-Q · filed 2022-08-03 | |||
| 2021-03-31 | -$11.88M 10-Q · filed 2022-05-02 | |||
| 2020-12-31 | $214.65M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $673.08M 10-Q · filed 2021-11-01 | |||
| 2020-06-30 | $795.92M 10-Q · filed 2021-08-02 | |||
| 2020-03-31 | -$3.19M 10-Q · filed 2021-05-03 | |||
| 2019-12-31 | $89.98M 10-K · filed 2022-02-28 | |||
| 2019-09-30 | $52.27M 10-Q · filed 2020-11-06 | |||
| 2019-06-30 | $16.43M 10-Q · filed 2020-07-29 | |||
| 2019-03-31 | $10.15M 10-Q · filed 2020-04-29 | |||
| 2018-12-31 | $383.26M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $415.68M 10-Q · filed 2019-10-30 | |||
| 2018-06-30 | $63.69M 10-Q · filed 2019-07-31 | |||
| 2017-12-31 | -$7.39M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |